Doxorubicin-induced Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Doxorubicin-induced Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity [Phase 2]
A Phase 2 clinical trial from Tanta University is evaluating whether dapagliflozin can prevent doxorubicin-induced cardiotoxicity in breast …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial at Tanta University evaluating telmisartan to prevent doxorubicin-induced cardiotoxicity in breast cancer patient…